IFNA1 and Zika virus infectious disease: These antiviral IFN-triggered ISGs exert diverse and different antiviral functions, such as inhibition of viral entry and viral protein synthesis, clearance of both viral protein and genome and inhibition of viral replication and release [183,185], as reported for ISG15 that limits ZIKV infection [186].